AIPTO TechBio pioneers a groundbreaking patient avatar technology utilizing patient tumor explants and organoids to faithfully replicate in vivo tumor biology. Augmenting this innovation is a cutting-edge generative AI technology driven by unparalleled single-cell RNA sequencing data obtained from these patient avatars. By synergizing the power of patient avatars with advanced AI capabilities, AIPTO is positioned to revolutionize drug discovery and precision medicine for brain cancer patients, offering a transformative path towards improved treatment outcomes.
Company Details
- Employees
- 2
- Address
- Aeschengraben 29, Basel,bs 4051,switzerland
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- HQ
- Basel, BS
Aipto Questions
Aipto's LinkedIn profile is https://ch.linkedin.com/company/aipto
Aipto has
2 employees.
View email and phone details for 2
employees at Aipto.
Aipto's industry is
Biotechnology Research
Aipto's top competitors are
Modiblast,
Immitra Bio Gmbh,
Orbit8,
Reach Therapeutics I.gr.,
Cantoni Therapeutics,
Brihaspati Ai,
Abyolo,
Heartbeat.bio Ag,
Autoderm,
Ats Aipto Ets.
Aipto's categories are Biotechnology Research
